Market closedNon-fractional

Treace Medical Concepts/TMCI

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX

About Treace Medical Concepts

Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The Company operates and manages its business as one segment, which is the business of designing, manufacturing, and marketing medical devices for physicians, surgeons, ambulatory surgery centers, and hospitals.

Ticker

TMCI

Sector

Healthcare

Trading on

NASDAQ

Industry

Health Care Equipment and Supplies

Headquarters

Ponte Vedra, United States

Employees

516

TMCI Metrics

BasicAdvanced
$410M
Market cap
-
P/E ratio
-$0.89
EPS
0.37
Beta
-
Dividend rate
$410M
0.37
3.983
2.999
54.79
55.473
-10.85%
-14.33%
-38.55%
2.078
3.24
3.91
-10.595
26.48%
5.81%
44.62%
86.16%

What the Analysts think about TMCI

Analyst Ratings

Majority rating from 7 analysts.
Hold

TMCI Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-36.39% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$51M
-17.85%
Net income
-$19M
200.00%
Profit margin
-36.39%
265.36%

TMCI Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 0.94%
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
-$0.20
-$0.28
-$0.10
-$0.30
-
Expected
-$0.24
-$0.26
-$0.09
-$0.30
-$0.29
Surprise
-16.08%
7.10%
12.90%
-0.94%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Treace Medical Concepts stock?

Treace Medical Concepts (TMCI) has a market cap of $410M as of July 06, 2024.

What is the P/E ratio for Treace Medical Concepts stock?

The price to earnings (P/E) ratio for Treace Medical Concepts (TMCI) stock is 0 as of July 06, 2024.

Does Treace Medical Concepts stock pay dividends?

No, Treace Medical Concepts (TMCI) stock does not pay dividends to its shareholders as of July 06, 2024.

When is the next Treace Medical Concepts dividend payment date?

Treace Medical Concepts (TMCI) stock does not pay dividends to its shareholders.

What is the beta indicator for Treace Medical Concepts?

Treace Medical Concepts (TMCI) has a beta rating of 0.37. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.

Buy or sell Treace Medical Concepts stock

Buy or sell Treace Medical Concepts stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing